Next-generation off-the-shelf CAR-NK cells derived from iPSCs for allogeneic immunotherapy of solid tumors.
Principal Investigator
Belen Alvarez
File
CPP2021-008350
Duration
2022 – 2025
Funded by
Agència Espanyola d'Investigació
Funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.
Objective
To produce a new generation of CAR-NK cells ready to use and equipped to overcome all the countermeasures that the tumor microenvironment can deploy.